Partner Content Partner Content Chairs from Aerie Pharmaceuticals & Santen Inc Invitation to... Ophthalmic Drugs Conference Invitation
Partner Content Partner Content Registration opens for SMi’s 4th Annual Ophthalmic Drugs Con... Registration opens for Ophthalmic Drugs Conference
Partner Content Partner Content Speaker Interview with iVeena Released for 3rd Ophthalmic Dr... Ophthalmic Drugs Conference Speaker Interview
Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.